研究单位:[1]Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.[2]LENZ Therapeutics, Inc[3]Eye Hospital, Wenzhou Medical University,Wenzhou,Zhejiang,China[4]Beijing Tongren Hospital, Capital Medical University,Beijing,China[5]Peking University First Hospital,Beijing,China[6]The Second Xiangya Hospital of Central South University,Changsha,China[7]Ineye Hospital of Chengdu University of TCM,Chengdu,China[8]Guang Zhou Aier eye Hospital,Guangzhou,China[9]Zhongshan Ophthalmic Center, Sun Yat-sen University,Guangzhou,China[10]The Affiliated Hospital of Guizhou Medical University,Guizhou,China[11]Henan Eye Hospital & Henan Institute,Henan,China[12]The affiliated Hospital of Inner Mongolia Medical University,Hohhot,China[13]Affiliated Eye Hospital, Shandong University of Traditional Chinese Medicine,Shandong,China[14]Shanghai Eye Disease Prevention and Treatment Center,Shanghai,China[15]Tongji Hospital Of Tongji University,Shanghai,China[16]Xinhua Hospital Affiliated to Shanghai Jiao Tong University School Of Medicine,Shanghai,China[17]Shanxi Eye Hospital,Shanxi,China[18]West China Hospital, Sichuan University,Sichuan,China[19]Tianjin Eye Hospital,Tianjin,China[20]Tianjin Medical University Eye Hospital,Tianjin,China[21]Wuhan Aier Eye Hospital,Wuhan,China[22]Xi'An People's Hospital,Xi'an,China